| Literature DB >> 24864131 |
Sevil Sema Atuğ Özcan1, Ismail Ceylan1, Erkan Ozcan2, Nezahat Kurt3, Ilhan Metin Dağsuyu4, Cenk Fatih Canakçi5.
Abstract
AIM: The aim of this study was to examine the changes in the levels of interleukine-1 beta (IL-1 β ), tumor necrosis factor alpha (TNF- α ), malondialdehyde (MDA), nitric oxide (NO), and 8-hydroxydeoxyguanosine (8-OHdG) in saliva and IL-1 β , TNF- α , and NO in gingival crevicular fluid (GCF) samples of patients with fixed orthodontic appliances. MATERIAL ANDEntities:
Mesh:
Substances:
Year: 2014 PMID: 24864131 PMCID: PMC4016902 DOI: 10.1155/2014/597892
Source DB: PubMed Journal: Dis Markers ISSN: 0278-0240 Impact factor: 3.434
Biochemical parameters of saliva prior to the treatment and at the first and sixth months.
| SALIVA |
| Pretreatment | Posttreatment 1st month | Posttreatment 6th month |
|
|---|---|---|---|---|---|
| Parameters | Mean ± std. | Mean ± std. | Mean ± std. | ||
| IL-1 | 50 | 40.80 ± 41.6 | 51.86 ± 61.20 | 40.98 ± 33.56 | 0.474 |
| TNF- | 50 | 18.99 ± 14.31 | 25.58 ± 25.66 | 21.18 ± 18.78 | 0.256 |
| MDA | 50 | 3.76 ± 2.48 | 3.87 ± 3.06 | 3.60 ± 2.45 | 0.984 |
| Nitrite | 50 | 4.58 ± 3.97 | 4.47 ± 4.25 | 3.78 ± 3.29 | 0.565 |
| 8-OHdG | 50 | 4.73 ± 4.15 | 5.38 ± 5.77 | 4.64 ± 4.03 | 0.942 |
Biochemical parameters of GCF prior to the treatment and at the first and sixth months.
| GCF |
| Pretreatment | Posttreatment 1st month | Posttreatment 6th month |
|
|---|---|---|---|---|---|
| Parameters | Mean ± std. | Mean ± std. | Mean ± std. | ||
| IL-1 | 50 | 10.69 ± 5.11 | 11.99 ± 6.74 | 13.41 ± 6.74 | 0.041* |
| TNF- | 50 | 6.83 ± 9.58 | 6.66 ± 3.80 | 6.81 ± 3.96 | 0.254 |
| Nitrite | 50 | 3.18 ± 1.71 | 3.56 ± 1.70 | 3.62 ± 2.07 | 0.096 |
*P < 0.05.
Clinical periodontal parameters measurements of GCF volume prior to the treatment and at the first and sixth months.
| Clinical parameters |
| Pretreatment | Posttreatment 1st month | Posttreatment 6th month |
|
|---|---|---|---|---|---|
| Mean ± Std. | Mean ± Std. | Mean ± Std. | |||
| PI | 50 | 0.12 ± 0.14 | 0.31 ± 0.28 | 0.20 ± 0.30 | 0.000* |
| GI | 50 | 0.07 ± 0.08 | 0.27 ± 0.28 | 0.31 ± 0.30 | 0.000* |
| PD | 50 | 1.48 ± 0.30 | 1.64 ± 0.30 | 1.73 ± 0.33 | 0.000* |
| GCF volume | 50 | 0.07 ± 0.02 | 0.08 ± 0.03 | 0.09 ± 0.07 | 0.136 |
*P < 0.05.
The results of Wilcoxon test to determine any significant difference between the periods in statistically significant parameters according to the Friedman test.
| Wilcoxon signed ranks test | ||||||
|---|---|---|---|---|---|---|
| Pretreatment—1st month | Treatment 1st–6th month | Pretreatment—6th month | ||||
|
| Sig. |
| Sig. |
| Sig. | |
| IL-1 | −1.78 | 0.074 | −1.34 | 0.181 | −3.05 | 0.002** |
| PI | −4.70 | 0.000*** | −0.056 | 0.955 | −4.41 | 0.000*** |
| GI | −5.16 | 0.000*** | −1.27 | 0.203 | −5.48 | 0.000*** |
| PD | −3.79 | 0.000*** | −2.14 | 0.032* | −4.61 | 0.000*** |
*P < 0.05, **P < 0.01, ***P < 0.001.